Delivery Order SPE2DB22D3011-SPE2DB25FQ2CV
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a firm fixed price ceiling value of $2,730.00. This competitive award, which is not set-aside, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline 25 mg/5 ml suspension in 60 ml quantities under a firm fixed-price contract valued at $1,829.98. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,238.08. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by June 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in a 60 mL quantity, with a ceiling value of $1,537.80. The contract employs firm fixed pricing with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,232.51 for Doxycycline 50 mg tablets (60-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $1,199.28 under a firm fixed price contract. This order represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Doxycycline 50 mg tablets (60-count units) with a ceiling value of $13,880.36. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 29, 2025. The award was issued on August 28, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for doxycycline 100 mg vials valued at $1,661.08. This competitive award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,830.34 to AmerisourceBergen Drug Corp for the supply of Doxycycline 100 mg vials. The contract, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2CVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,902.88 to AmerisourceBergen Drug Corp for the supply of Doxycycline 25 mg/5 ml Suspension in 60 ml quantities. This competitive award, which was not set-aside, was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and carries firm fixed price terms. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement transaction under the company's existing contract vehicle with the Defense Logistics Agency. This award is issued as a child delivery order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to support military healthcare operations worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that consistently fulfills DLA requirements through competitive awards across multiple therapeutic domains, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/6/25 |